Publicaciones en colaboración con investigadores/as de Duke University (32)

2021

  1. Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM

    The Lancet Infectious Diseases, Vol. 21, Núm. 12, pp. e375-e386

2018

  1. Endemic fungal infection recommendations for solid-organ transplant recipients and donors

    Transplantation, Vol. 102, Núm. 2S, pp. S52-S59

2017

  1. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis

    Clinical Microbiology and Infection, Vol. 23, Núm. 8, pp. 544-549

2016

  1. The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary

    Journal of Heart and Lung Transplantation

2015

  1. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis a prospective study from the international collaboration on endocarditis

    Circulation, Vol. 131, Núm. 2, pp. 131-140

  2. Candida infective endocarditis: An observational cohort study with a focus on therapy

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 4, pp. 2365-2373

  3. Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the international collaboration of endocarditis-prospective cohort study

    Clinical Infectious Diseases, Vol. 60, Núm. 5, pp. 741-749

  4. One-year outcome following biological or mechanical valve replacement for infective endocarditis

    International Journal of Cardiology, Vol. 178, pp. 117-123

2013

  1. HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort

    PLoS ONE, Vol. 8, Núm. 5

  2. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis

    JAMA Internal Medicine, Vol. 173, Núm. 16, pp. 1495-1504

  3. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke

    Clinical Infectious Diseases, Vol. 56, Núm. 2, pp. 209-217

2010

  1. Identifying predictors of central nervous system disease in solid organ transplant recipientswith cryptococcosis

    Transplantation, Vol. 89, Núm. 1, pp. 69-74

  2. Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 29, Núm. 10, pp. 1203-1210

  3. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients

    Clinical Infectious Diseases, Vol. 51, Núm. 9, pp. 1062-1069

2009

  1. Coagulase-negative staphylococcal prosthetic valve endocarditis-a contemporary update based on the International Collaboration on Endocarditis: Prospective cohort study

    Heart, Vol. 95, Núm. 7, pp. 570-576

  2. Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis

    Clinical Infectious Diseases, Vol. 49, Núm. 11, pp. 1721-1728

2008

  1. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis

    Antimicrobial Agents and Chemotherapy, Vol. 52, Núm. 2, pp. 735-738

  2. Central nervous system cryptococcosis in solid organ transplant recipients: Clinical relevance of abnormal neuroimaging findings

    Transplantation, Vol. 86, Núm. 5, pp. 647-651

  3. Pulmonary cryptococcosis in solid organ transplant recipients: Clinical relevance of serum cryptococcal antigen

    Clinical Infectious Diseases, Vol. 46, Núm. 2

  4. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Clinical Infectious Diseases, Vol. 46, Núm. 12, pp. 1813-1821